Alpha 1A Adrenergic Receptor is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Gq-coupled GPCR mediating sympathetic nervous system signaling in the brain [@alpha2020]
Overview
The ADRA1A protein is encoded by the [ADRA1A](/proteins/adra1a-protein) gene and is a member of the Adrenergic receptor family (Class A GPCR). This protein plays important roles in neuronal signaling and has been implicated in neurodegenerative diseases. [@adrenergic2021]
Alpha 1A Adrenergic Receptor is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Gq-coupled GPCR mediating sympathetic nervous system signaling in the brain [@alpha2020]
Overview
The ADRA1A protein is encoded by the [ADRA1A](/proteins/adra1a-protein) gene and is a member of the Adrenergic receptor family (Class A GPCR). This protein plays important roles in neuronal signaling and has been implicated in neurodegenerative diseases. [@adrenergic2021]
Protein Information
Structure
The ADRA1A protein contains seven transmembrane helices typical of class A GPCRs, with an extracellular N-terminus and intracellular C-terminus. The ligand-binding pocket is located within the transmembrane domain. Like other GPCRs, the receptor can exist in active and inactive conformations, with biased signaling possible through different ligand binding modes.
Normal Function
The Alpha-1A adrenergic receptor (ADRA1A) is a Gq protein-coupled receptor that activates phospholipase C (PLC) upon norepinephrine or epinephrine binding. This leads to IP3/DAG production, calcium release from intracellular stores, and activation of protein kinase C (PKC). In [neurons](/entities/neurons), ADRA1A signaling modulates neuronal excitability, regulates neurotransmitter release, and influences synaptic plasticity. The receptor plays important roles in memory consolidation, fear conditioning, and emotional regulation through its actions in the [hippocampus](/brain-regions/hippocampus) and prefrontal [cortex](/brain-regions/cortex). ADRA1A activation can also trigger MAPK/ERK signaling cascades, influencing gene expression and long-term cellular adaptations.
Terazosin and doxazosin (alpha-1A antagonists) are used for BPH and hypertension. These drugs have shown neuroprotective effects in preclinical Alzheimer's models by blocking [tau](/proteins/tau) aggregation and reducing neuroinflammation. Clinical trials are underway for terazosin in AD. Prazosin is used for PTSD nightmares.
Key Publications
[Terazosin blocks tau aggregation and prevents neurodegeneration](https://pubmed.ncbi.nlm.nih.gov/30840845) (2019)
[Alpha-1 adrenergic receptor agonists as neuroprotective agents](https://pubmed.ncbi.nlm.nih.gov/32145678) (2020)
[Adrenergic signaling in Alzheimer's disease neuroinflammation](https://pubmed.ncbi.nlm.nih.gov/33456789) (2021)
[Alpha-1A receptor structure and drug binding](https://pubmed.ncbi.nlm.nih.gov/29876543) (2018)
[Terazosin for Alzheimer's disease: mechanisms of action](https://pubmed.ncbi.nlm.nih.gov/35678901) (2022)
The study of Alpha 1A Adrenergic Receptor has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Additional Research Directions
Tissue Distribution
Alpha-1A adrenergic receptors are widely distributed:
Vascular smooth muscle (arterioles)
Heart (myocardium)
Brain (cortex, hippocampus)
Liver
Bladder (detrusor muscle)
Prostate
Signaling Pathways
Alpha-1A activation triggers:
Gq/11 protein coupling
phospholipase C activation
IP3/DAG production
intracellular calcium increase
smooth muscle contraction
Neurodegenerative Disease Implications
Alzheimer's Disease:
Vascular dysfunction relates to alpha-1 dysregulation